Invivac; influenza virus vaccine, inactivated, virosomal, cell cultured -- Product Record

Influenza vaccine, virosomal/Solvay

    Nomenclature:
      Influenza vaccine, virosomal/Sanofi [BIO]
      Invivac [TR]
      Influenza Virus Vaccine [FDA USAN]
      influenza virus vaccine, inactivated, virosomal, cell cultured [SY]

    FDA Class:  Biologic BLA

    Annual sales (2008, $millions) = $198

Index Terms:

  • Product Class Index:
      biopharmaceutical products
      lipoproteins
      vaccines, inactivated
      vaccines, intranasal
      vaccines, subunit
      vaccines, viral
  • Biological Index:
      cancer, thyroid
      influenza virus
      keratinocytes, human
      Mab 1129, murine monoclonal antibody
      mammalian cell culture
      virus culture
  • Chemical Index:
      beta-propiolactone (BPL; beta propiolactone)
      beta-propiolactone (BPL; beta propiolactone)
      disodium hydrogen phosphate
      hemagglutinin (HA) antigen, influenza A virus
      influenza virus
      influenza virus
      Latrodectus mactans
      lipoproteins
      neuraminidase
      phospholipases
      potassium dihydrogen phosphate
      sodium chloride
      Sterile Water for Injection
      viral inactivation, unspecified
  • Source/Host/Expression System: Madin Darby Canine Kidney (MDCK) cells
  • Regulatory/Status Index:
      North American coral snake
      EU200 Currently Approved in EU
      UM999 Not Available/Not Marketed in US
      US000 never filed/no plans
      EM001 Marketed Product in EU